Open AccessANTI-IL-6 ANTIBODY CLAZAKIZUMAB IN LATE ANTIBODY-MEDIATED REJECTION – MOLECULAR REBOUND PHENOMENA UNDER IL-6 BLOCKADE?
Author(s) -
Anita Borski,
Susanne Haindl,
Michael Dürr,
Klemens Budde,
Sabine Schranz,
Farsad Eskandary,
Konstantin Doberer,
Philip F. Halloran,
Edward Chong,
Bernd Jilma,
Georg A. Böhmig,
Markus Wahrmann
Publication year - 2020
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000698588.88678.f6
Subject(s) - medicine , placebo , blockade , cytokine , antibody , interleukin 6 receptor , immunology , clinical endpoint , interleukin , receptor , clinical trial , gastroenterology , pathology , alternative medicine